268 related articles for article (PubMed ID: 21425123)
1. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.
Lenna S; Farina AG; Martyanov V; Christmann RB; Wood TA; Farber HW; Scorza R; Whitfield ML; Lafyatis R; Trojanowska M
Arthritis Rheum; 2013 May; 65(5):1357-66. PubMed ID: 23400395
[TBL] [Abstract][Full Text] [Related]
3. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
4. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.
Lenna S; Assassi S; Farina GA; Mantero JC; Scorza R; Lafyatis R; Farber HW; Trojanowska M
Arthritis Res Ther; 2015 Dec; 17():363. PubMed ID: 26669670
[TBL] [Abstract][Full Text] [Related]
5. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Tu J; Jin J; Chen X; Sun L; Cai Z
Front Immunol; 2022; 13():868983. PubMed ID: 35663995
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
Zhang T; Huang C; Luo H; Li J; Huang H; Liu X; Zhan S
Life Sci; 2021 Apr; 271():119151. PubMed ID: 33539912
[TBL] [Abstract][Full Text] [Related]
9. 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension.
Joven BE; Escribano P; Andreu JL; Loza E; Jimenez C; de Yebenes MJG; Ruiz-Cano MJ; Carmona L; Carreira PE
Semin Arthritis Rheum; 2018 Jun; 47(6):870-876. PubMed ID: 29126717
[TBL] [Abstract][Full Text] [Related]
10. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
13. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
14. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R
Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
Kylhammar D; Hesselstrand R; Nielsen S; Scheele C; Rådegran G
Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
[TBL] [Abstract][Full Text] [Related]
17. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
[TBL] [Abstract][Full Text] [Related]
19. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.
Pendergrass SA; Hayes E; Farina G; Lemaire R; Farber HW; Whitfield ML; Lafyatis R
PLoS One; 2010 Aug; 5(8):e12106. PubMed ID: 20808962
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis.
Kumar U; Ramteke R; Yadav R; Ramam M; Handa R; Kumar A
J Assoc Physicians India; 2008 Jun; 56():413-7. PubMed ID: 18822619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
